Guangji Pharmaceutical (000952.SZ) Invests RMB 20 million to Establish Wuhan Subsidiary for Increasing Technical Innovation

Search by Type

Report Charts News

Search by Company

Code Company name

Guangji Pharmaceutical (000952.SZ) Invests RMB 20 million to Establish Wuhan Subsidiary for Increasing Technical Innovation

Date:2011-12-14liaoyan

Guangji Pharmaceutical (000952.SZ) announced that the company intends to invest RMB20 million by cash and assets to set up Hubei Puji Industrial Microbiology Applied Technology Development Co., Ltd...

Welcome to our website. This service is open to member only.

Registration

Contact our customer service team
Tel: 86-10-82600828, 82600893
Fax: 86-10-82601570
Email: report@researchinchina.com

Related Reports

China Heparin Industry Report, 2010-20112011-09-28
China Blood Products Industry Report, 2010-20112011-09-05
China Monoclonal Antibody Industry Report, 2010-20112011-07-05
China Insulin Industry Report, 20102011-01-25
China Heparin Industry Report, 20102010-12-18
China Blood Products Industry Report, 20102010-11-10
Global and China Biopharmaceutical Industry Report, 20102010-09-16
China Blood Products Industry Report, 20092009-10-13